The Pennine Acute Hospitals
NHS Trust Formulary
 
back
2 Cardiovascular system
02-12 Other lipid modifying agents

Evolocumab Repatha®
First Choice
Pre-filled syringe
Pre-filled pen
Only as per NICE TA394.
Requires completion of Blueteq form prior to initiation.
Available via Homecare providers.
Link  NICE TA394: Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
Link  GMMMG Recommendation: PCSK9 inhibitors in the treatment of hypercholesterolaemia
 

Red View adult BNF  View SPC online  HCD
Alirocumab Praluent®
Second Choice
Pre-filled syringe
Pre-filled pen
Restricted Item For patients with latex allergy or intolerance to evolocumab

Only as per NICE TA393.
Requires completion of Blueteq form prior to initiation.
Available via Homecare providers.
Link  NICE TA393: Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
Link  GMMMG Recommendation: PCSK9 inhibitors in the treatment of hypercholesterolaemia
 

Red View adult BNF  View SPC online  HCD